Outcome of Graves' orbitopathy after total thyroid ablation and glucocorticoid treatment: Follow-up of a randomized clinical trial

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 1, 2012, Pages

  Leo, Marenza ^a   Marcocci, Claudio ^a   Pinchera, Aldo ^a   Nardi, Marco ^a   Megna, Loredana ^a   Rocchi, Roberto ^a   Latrofa, Francesco ^a   Altea, Maria Antonietta ^a   Mazzi, Barbara ^a   Sisti, Eleonora ^a   Profilo, Maria Antonietta ^a   Marinò, Michele ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IODINE 131;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCRINE OPHTHALMOPATHY; EYE EXAMINATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; THYROIDECTOMY; TREATMENT DURATION;

ADULT; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; REMISSION INDUCTION; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84855487522     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2077     Document Type: Article

References (15)

1. Bahn RS 2010 Graves' ophthalmopathy. N Engl J Med 362:726-738
2. Wiersinga WM 2007 Management of Graves' ophthalmopathy. Nat Clin Pract Endocrinol Metab 3:396-404 (Pubitemid 46650669)
3. Bartalena L, Tanda ML 2009 Clinical practice. Graves' ophthalmopathy. N Engl J Med 360:994-1001
4. Bartalena L, Wiersinga WM, Pinchera A 2004 Graves' ophthalmopathy: state of the art and perspectives. J Endocrinol Invest 27:295-301 (Pubitemid 38607484)
5. Bartalena L, Marcocci C, Tanda ML, Piantanida E, Lai A, MarinòM, Pinchera A 2005 An update on medical management of Graves' ophthalmopathy. J Endocrinol Invest 28:469-478 (Pubitemid 43162746)
6. Marinò M, Chiovato L, Lisi S, Altea MA, Marcocci C, Pinchera A 2004 Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: the hypothesis of Kriss revisited. J Endocrinol Invest 27:230-236 (Pubitemid 38607475)
7. Catz B, Perzik SL 1969 Total thyroidectomy in the management of thyrotoxic and euthyroid Graves' disease. Am J Surg 118:434-439
8. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L, Pinchera A 2003 Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Int Med 139:346-351
9. DeGroot LJ, Benjasuratwong Y 1996 Evaluation of thyroid ablative therapy for ophthalmopathy of Graves' disease. Orbit 15:187-196 (Pubitemid 26292640)
10. Moleti M, Mattina F, Salamone I, Violi MA, Nucera C, Baldari S, Lo Schiavo MG, Regalbuto C, Trimarchi F, Vermiglio F 2003 Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of Graves' ophthalmopathy. Thyroid 13:653-658 (Pubitemid 36993561)
11. Menconi F, Marinò M, Pinchera A, Rocchi R, Mazzi B, Nardi M, Bartalena L, Marcocci C 2007 Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids. J Clin Endocrinol Metab 92:1653-1658 (Pubitemid 46997167)
12. Marcocci C, Menconi F, Marino M, Rocchi R, Pinchera A 2007 Reply to Professor Wiersinga's letter. J Clin Endocrinol Metab, electronic letters, July 13, 2007: http://jcem.endojournals.org/cgi/eletters/92/5/1653#13513
13. Pinchera A, Wiersinga W., Glinoer D, Kendall-Taylor P, Koorneef L, Marcocci C, Schleusener H, Romaldini J, Niepominiscze H, Nagataki S, Izumi M, Inoue M, Stockigt J, Wall J, Greenspan F, Solomon D, Garrity J, Gorman CA 1992 Classification of eye changes of Graves' disease. Thyroid 2:235-236
14. Bartalena L, Baldeschi L, Dickinson AJ, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits MP, Perros P, Boboridis K, Boschi A, CurròN, Daumerie C, Kahaly GJ, Krassas G, Lane CM, Lazarus JH, Marinò M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM 2008 Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid 18:333-346 (Pubitemid 351415802)
15. Eckstein A, Esser J, Mann K, Schott M 2010 Clinical value of TSH receptor antibodies measurement in patients with Graves' orbitopathy. Pediatr Endocrinol Rev 7 (Suppl 2):198-203